Open-Label Pilot Study to Compare the Safety and Immunogenicity of Pentavalent Rotavirus Vaccine (RV5) Administered on an Early Alternative Dosing Schedule with Those of RV5 Administered on the Recommended Standard Schedule.

Published

Journal Article

This study compares the safety and immunogenicity of pentavalent rotavirus vaccine (RV5) administered on an alternative schedule (initiated at 2-5 weeks of age) with those of RV5 administered on the recommended standard schedule. Our findings support the future conduct of larger clinical trials to confirm the safety and efficacy of rotavirus vaccination in the neonatal period.

Full Text

Duke Authors

Cited Authors

  • Saleh, E; Eichner, B; Clark, DW; Gagliano, ME; Troutman, JM; Harrington, L; McNeal, M; Clements, D

Published Date

  • February 19, 2018

Published In

Volume / Issue

  • 7 / 1

Start / End Page

  • 82 - 85

PubMed ID

  • 28340179

Pubmed Central ID

  • 28340179

Electronic International Standard Serial Number (EISSN)

  • 2048-7207

Digital Object Identifier (DOI)

  • 10.1093/jpids/pix005

Language

  • eng

Conference Location

  • England